KalshiCheck availabilityKYC required2% feeVerified resolution dataFairly calibratedCurrent implied probability
Before 2028 72%Leader of 3 outcomes
Market quality
46 / 100
Low quality24h Volume
$525
Liquidity
$2.5K
Low liquiditySpread
6.0 pt
Wide spreadMarket data
Updated 6 minutes ago
Mar 24, 26, 2:00 PM UTCJul 1, 27, 3:59 AM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
When will Intellia Therapeutics submit a BLA for Lonvo-z?
KalshiWill the FDA approve retatrutide?
KalshiWill the FDA approve any psychedelic substance for medical use this year?
KalshiWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Manifold MarketsRules
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.
Open markets
Health & Medicine
POLYMARKETEbola pandemic in 2026?
- No+1.1pt97%
- Yes-1.1pt3%
- Total Vol
- $755.4K
- 24h Vol
- $34.5K
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Total Vol
- $18.1M
- 24h Vol
- $22.8K
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Total Vol
- $1.9M
- 24h Vol
- $6K
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt64%
- September+2.0pt41%
- June28%
- Total Vol
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+62.0pt96%
- before November+31.0pt84%
- before 2027+8.0pt84%
+3 more outcomes
POLYMARKETNew pandemic in 2026?
- No93.1%
- Yes6.9%
- Total Vol
- $1.1M
- 24h Vol
- $3.8K
- Measles cases in 2026?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Measles cases in U.S. in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA approves Retatrutide this year?
- Which countries will report an Ebola case in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- Which countries will report an Ebola disease case before October?
Frequently asked questions
- What are the current odds for When will the FDA approve Intellia Therapeutics' lonvo-z??
- Kalshi prices Before 2028 at 72% as of September 8, 2026.
- When does When will the FDA approve Intellia Therapeutics' lonvo-z? resolve?
- When will the FDA approve Intellia Therapeutics' lonvo-z? is scheduled to resolve on July 1, 2027.
- How is When will the FDA approve Intellia Therapeutics' lonvo-z? settled?
- Kalshi settles this market as follows: If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.